“Analyzing AVSU: Could Its Value Reach $77?”

Avatar photo

Avantis Responsible U.S. Equity ETF Shows Potential Growth

In an analysis by ETF Channel, we looked at the Avantis Responsible U.S. Equity ETF (Symbol: AVSU) and compared its holdings against analyst target prices. The estimated target for the ETF is set at $77.26 per unit.

Currently, AVSU trades around $69.06, suggesting an 11.87% upside based on these analyst forecasts. Among its top holdings, notable stocks with significant potential include Merus NV (Symbol: MRUS), GXO Logistics Inc (Symbol: GXO), and Elanco Animal Health Inc (Symbol: ELAN). For instance, MRUS, trading at $45.07, has an average analyst target of $86.12, reflecting a 91.09% increase. Similarly, GXO could rise 51.79% from its current price of $40.44 if it meets the target price of $61.38. Analysts also expect ELAN to climb 50.36% from its recent valuation of $11.24 to reach a target of $16.90. Below is a visual representation of the twelve-month stock performance for MRUS, GXO, and ELAN:

MRUS, GXO, and ELAN Relative Performance Chart

Here’s a summary of the current analyst targets for these stocks:

Name Symbol Recent Price Avg. Analyst 12-Mo. Target % Upside to Target
Avantis Responsible U.S. Equity ETF AVSU $69.06 $77.26 11.87%
Merus NV MRUS $45.07 $86.12 91.09%
GXO Logistics Inc GXO $40.44 $61.38 51.79%
Elanco Animal Health Inc ELAN $11.24 $16.90 50.36%

These target prices lead to questions about whether analysts are being realistic or overly optimistic regarding future stock performance. Investigating the context behind these estimates is crucial for investors. A large gap between a stock’s current price and the analyst target could indicate growth potential, but it’s essential to assess whether the targets reflect recent industry shifts or if they stem from outdated assessments.

10 ETFs With Most Upside To Analyst Targets »

Also see:

• CPAA Videos
• Top Ten Hedge Funds Holding LNFA
• DD Technical Analysis

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

The free Daily Market Overview 250k traders and investors are reading

Read Now